YOU ARE HERE: LAT HomeCollectionsDefibrillators


November 21, 2007 | From Times Wire Services
Medtronic Inc. has agreed to pay about $130 million to settle claims that it hid defects in heart defibrillators, adding $55 million to an amount proposed in July, three people with direct knowledge of the deal said. The extra money will allow Medtronic to resolve about 2,600 claims, 600 more than were envisioned in the $75-million initial settlement, the people said. The company agreed to the higher amount last month after more claims were filed over the devices than expected, the people said.
November 12, 2007 | From wire reports
Researchers attending the American Heart Assn.'s annual meeting in Orlando, Fla., last week reported the results from a plethora of heart-related studies. Among the findings . . . Bystanders using battery-powered defibrillators may be saving more than 500 lives every year in the United States and Canada alone. "Good Samaritans, when given access to automated defibrillators in potentially fatal emergencies, save lives," Dr.
October 22, 2007 | Mary Beckman, Special to The Times
Last week, the Food and Drug Administration and heart device maker Medtronic told doctors to stop using a particular component -- the wire lead -- of Medtronic's latest generation of implanted heart defibrillators. Cardiologist Dr. William Maisel, a consultant to the FDA, explains what these devices do and what went wrong. What are these implantable heart devices? Implantable heart devices come in two types. The more common device, a pacemaker, is designed for hearts that beat too slowly.
October 16, 2007 | From the Associated Press
Medtronic Inc. warned doctors Monday that the wires connecting a patient's heart to the firm's implantable defibrillators break too often. The news knocked Medtronic shares down $6.33 or 11.2% to $50. Medtronic told doctors to stop using the Sprint Fidelis wires after linking five deaths to breaks in them. The company said the Fidelis wires failed slightly more often than the thicker wires they were meant to replace. The problem does not affect Medtronic pacemakers.
October 3, 2007 | Thomas H. Maugh II, Times Staff Writer
Elderly male heart patients are two to three times more likely than females to receive implanted devices that shock a malfunctioning heart back into normal rhythms, and white men are about a third more likely than black men to receive them, researchers reported today. Overall, only about a third of patients who are eligible for the potentially lifesaving implanted cardioverter defibrillators are actually getting them, according to a pair of studies in the Journal of the American Medical Assn.
August 31, 2007 | From the Associated Press
Boston Scientific Corp. said Thursday that three of its subsidiaries agreed to pay $16.75 million and extend the warranty on some of its heart devices as part of a settlement with state attorneys general over defibrillator recalls. The affected devices were manufactured by Indianapolis-based Guidant Corp., which Natick, Mass.-based Boston Scientific acquired last year.
July 30, 2007 | From Times wire reports
Researchers toting up the pluses and minuses of implanting defibrillators in the chests of people with a potentially fatal heart defect said last week that the devices could save lives, but could also expose patients to deadly risks. An estimated 500,000 Americans were born with a genetic heart defect that causes a condition called hypertrophic cardiomyopathy, or HCM, that can cause the heart to beat abnormally and damage the heart muscle.
July 21, 2007 | From Times Wire Services
Heart device maker Medtronic Inc. has agreed to pay more than $75 million to settle lawsuits claiming it hid defects in its defibrillators, people with direct knowledge of the accord said. The settlement will resolve about 2,000 claims over battery defects in Medtronic's implantable defibrillators, which automatically send electric jolts to correct heart rhythms that are potentially fatal.
May 27, 2007 | From the Associated Press
June Daugherty was saved from cardiac arrest and death through extraordinary fortune on Tuesday. Now she begins life with the defibrillator that doctors installed in her chest on Thursday. She can ask Kayla Burt for advice. Daugherty, Washington State's women's basketball coach, and Burt, her former player at Washington, share the same rare condition: cardiomyopathy. Both went into cardiac arrest. Both were seconds from dying. Yet both are alive and in basketball.
Los Angeles Times Articles